Abdera Therapeutics
Stella Chin, CPA, has extensive experience in accounting and finance roles, including positions as Controller, Finance Accounting Manager, Assistant Corporate Controller, and Senior Accountant at various companies such as Abdera Therapeutics, Epicor, Kodak Graphic Communications Company, AMEC Engineering, and Steffen Robertson & Kirsten Consulting Engineers Inc. With a background in full cycle accounting, cost accounting, financial analysis, and business unit finance, Stella also has skills in FP&A including budgeting, forecasting, and variance analysis. Stella's educational background includes a Bachelor's degree in Business/Commerce, Accounting, and Stella is a Certified Public Accountant (CPA) Canada.
Abdera Therapeutics
1 followers
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.